Essential Pharmaceuticals, LLC was established in 2006 with the distribution rights to Custodiol® HTK organ preservation solution. Essential's Sales and Marketing team grew Custodiol in the U.S. to be one of the top two organ preservation solution and is the only preservation solution approved by the FDA for heart transplant. Essential continues to grow Custodiol and is seeking currently new indications at the FDA.